REGENERX BIOPHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCKRegenerx Biopharmaceuticals Inc • October 5th, 2009 • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, CHAUMIERE-CONSULTADORIA & SERVICOS SDC UNIPESSOAL LDA, or its permitted registered assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from REGENERX BIOPHARMACEUTICALS, INC., a Delaware corporation (the “Company”) up to 609,756 shares of the common stock of the Company, par value $0.001 per share (the “Common Stock”). This Warrant has been issued pursuant to that certain Securities Purchase Agreement between the Company and the Holder dated as of September 30, 2009 (the “Purchase Agreement”).
REGENERX BIOPHARMACEUTICALS, INC. SECURITIES PURCHASE AGREEMENT SEPTEMBER 30, 2009Securities Purchase Agreement • October 5th, 2009 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations
THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of September 30, 2009, is entered into by and between RegeneRx Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and Chaumiere-Consultadoria & Servicos SDC Unipessoal LDA (hereinafter the “Investor”).
